Perianal Paget’s disease (PPD) is a rare intraepithelial adenocarcinoma of the anal margin. Primary PPD likely represents intra-epithelial neoplasm from an apocrine source, whereas secondary disease may represent “pagetoid” spread from an anorectal malignancy.
Histologic CDX-2 and CK20 are hallmark markers for colorectal-derived Paget’s cells. Interestingly, our primary PPD patient presented both positive and no internal malignancy was identified. In addition, a negative CK7 marker was observed in our case in contrast with previously reported. Surgical excision is the standard treatment; however, previous studies have demonstrated good response with Imiquimod 5% cream in patients with vulval extramammary Paget disease (EMPD). The efficiency of Imiquimod treatment for PPD has not been well described. Our PPD patient was successfully treated using Imiquimod 5% cream.
This study describes a primary cutaneous PPD patient CDX-2+/CK20+/CK7- without invasion of the dermis and no associated colorectal carcinoma effectively treated using topical Imiquimod therapy, suggesting that Imiquimod might potentially be considered as a first-line treatment for PPD.
Paget J. On the disease of the mammary gland areola preceding cancer of the mammary gland. St Bartholomew’s Hosp Rep. 1874;10:87–9.
Lam C, Funaro D. Extramammary Paget's disease: summary of current knowledge. Derm Clin. 2010;(4):807–26. CrossRef
Kyriazanos ID, Stamos NP, Miliadis L, Noussis G, Stoidis CN. Extra-mammary Paget's disease of the perianal region: a review of the literature emphasizing the operative management technique. Surg Oncol. 2011;(2):e61–71. CrossRef
Park JS, Kerner BA. Perianal Paget’s disease. Semin Colon Rectal Surg. 2003;14:218–21. CrossRef
Tanaka VDA, Sanches JA, Torezan L, Niwa AB, Neto CF. Mammary and extramammary paget’s disease: a study of 14 cases and the associated therapeutic difficulties. Clinics (São Paulo). 2009;6:599–606.
Trindade ES, Polcheira PA, Basílio DB, Rocha ZN, Rocha Júnior JL, Primo GRP. Doença de Paget invasiva da vulva e região perianal: Relato de Caso. Rev Bras Ginecol Obstet. 2004;(4):329–35. CrossRef
Huang SW, Liu KT, Chang CC, Chen YJ, Wu CY, Tsai JJ, Lu WC, Wang YT, Liu CM, Shieh JJ. Imiquimod simultaneously induces autophagy and apoptosis in human basal cell carcinoma cells. Br J Dermatol. 2010;(2):310–20. CrossRef
Kemeny L, Nagy N. New perspective in immunotherapy: local imiquimod treatment. Orv Hetil. 2010;151:774–83. CrossRef
Fehres CM, Bruijns SC, van Beelen AJ, Kalay H, Ambrosini M, Hooijberg E, Unger WW, Gruijil TD, Van KY. Topical rather than intradermal application of the TLR7 ligand imiquimod leads to human dermal dendritic cell maturation and CD8+ T-cell cross-priming. Eur J Immunol. 2014;8:2415–24. CrossRef
Isik O, Aytac E, Brainard J, Valente MA, Abbas MA, Gorgun E. Perianal Paget's disease: three decades experience of a single institution. Int J Color Dis. 2016;(1):29–34. CrossRef
Kim TH, Chang IH, Kim TH, Lee SY, Myung SC. Extramammary Paget's disease of scrotum treated with radiotherapy. Urology. 2009;2:474–3.
Grow JR, Kshirsagar V, Tolentino M. Extramammary perianal Paget’s disease: a report of a case. Dis Colon Rectum. 1997;5:436–42.
Jankulovski N, Spasevska L, Janevska V, Dukova B. A true epidermotropic apocrine neoplasm in the form of perianal Paget’s disease: a case report. J Med Case Rep. 2013;7:162–6. CrossRef
De Nisi MC, D’Amuri A, Toscano M, Lalinga AV, Pirtoli L, Miracco C. Usefulness of CDX2 in the diagnosis of extramammary Paget disease associated with malignancies of intestinal type. Br J Dermatol. 2005;(3):677–9.
Zeng HA, Cartun R, Ricci A Jr. Potential diagnostic utility of CDX-2 immunophenotyping in extramammary Paget’s disease. Appl Immunohistochem Mol Morphol. 2005;(4):342–6. CrossRef
Ramalingam P, Hart WR, Goldblum JR. Cytokeratin subset immunostaining in rectal adenocarcinoma and normal anal glands. Arch Pathol Lab Med. 2001;8:1074–7.
Lora V, Kanitakis J. CDX2 expression in cutaneous metastatic carcinomas and extramammary Paget’s disease. Anticancer Res. 2009;12:5033–7.
Le Fur R, Mears L, Dannawi Z. A perianal extramammary Paget’s disease associated with two well-differentiated invasive intramucosal sigmoid carcinomas, a very rare case: an immunohistochemical and clinical review of extramammary Paget’s disease. Ann R Coll Surg Engl 2004; 6:w26–w31.
Knight SR, Proby C, Ziyaie D, Carey F, Koch S. Extramammary Paget disease of the perianal region: the potential role of imiquimod in achieving disease control. J Surg Case Rep. 2016;(8):1–3. CrossRef
Kaufmann O, Koch S, Burghardt J, Audring H, Dietel M. Tyrosinase, melan-a, and KBA62 as markers for the immunohistochemical identification of metastatic amelanotic melanomas on paraffin sections. Mod Pathol. 1998;8:740–6.
Takahagi S, Noda H, Kamegashira A, Madokoro N, Hori I, Shindo H, Mihara S, Esconder M. Metastatic extramammary Paget's disease treated with paclitaxel and transtuzumab combination chemotherapy. J Dermatol. 2009;(8):457–61. CrossRef
Memezawa A, Okuyama R, Tagami H, Aiba S. P63 constitutes a useful histochemical marker for differentiation of Pagetoid Bowen’s disease from Extramammary Paget’s disease. Acta Derm Venereol. 2008;6:619–20.
Murakami K, Tanimura H, Ishimoto K, Yamaue H, Yamade N, Shimamoto T. Reconstruction with bilateral gluteus maximus myocutaneous rotation flap after wide local excision for perianal extramammary Paget's disease. Report of two cases Dis Colon Rectum. 1996;(2):227–31. CrossRef
Lam DT, Batista O, Weiss EG, Nogueras JJ, Wexner SD. Staged excision and split-thickness skin graft for circumferential perianal Paget's disease. Dis Colon Rectum. 2001;(6):868–70. CrossRef
McCarter MD, Quan SH, Busam K, Paty PP, Wong D, Guillem JG. Long-term outcome of perianal Paget's disease. Dis Colon Rectum. 2003;(5):612–6. CrossRef
Brown RS, Lankester KJ, McCormack M. Radiotherapy for perineal Paget’s disease. Clin Oncol. 2002;(4):272–84.
Thirlby RC, Hammer CJ Jr, Galagan KA, Travaglini JJ, Picozzi VJ Jr. Perianal Paget's disease: successful treatment with combined chemoradiotherapy. Report of a case. Dis Colon Rectum. 1990;(2):150–2.
Kobayashi H, Someda Y, Furukawa M, Chanoki M, Hamada T. Intralesional interferon in the treatment of extramammary Paget’s disease. Nihon Hifuka Gakkai Zasshi. 1987;1:1–7.
Vereecken P, Awada A, Ghanem G, Marques da Costa C, Larsimont D, Simoens C, Mendes CP, Hendkisz U. A therapeutic approach to perianal extramammary Paget's disease: topical imiquimod can be useful to prevent or defer surgery. Med Sci Monit. 2007;6:CS75–7.
Shutze WP, Gleysteen JJ. Perianal Paget's disease. Classification and review of management: report of two cases. Dis Colon Rectum. 1990;(6):502–7.
- Rare perianal extramammary Paget disease successfully treated using topical Imiquimod therapy
Jéssica Silva dos Santos
Gabriel Alves Bonafé
José Aires Pereira
Danilo Toshio Kanno
Carlos Augusto Real Martinez
Manoela Marques Ortega
- BioMed Central
Neu im Fachgebiet Onkologie
Colonoscopy examination/© dos Santos et al., Mail Icon II